EVA MUTTO: Open Payments
NPI 1306119854 · NORTH CHELMSFORD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$848 in 35 payments from 8 companies in 2025. Trend: 2023 $668 · 2024 $762 · 2025 $848
Food & beverage: $848
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $328 |
| ABBVIE INC. | 12 | $231 |
| Janssen Pharmaceuticals, Inc | 3 | $85 |
| Otsuka America Pharmaceutical, Inc. | 4 | $84 |
| Lundbeck LLC | 2 | $44 |
| Axsome Therapeutics, Inc. | 1 | $31 |
| Teva Pharmaceuticals USA, Inc. | 1 | $30 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
Products named: CAPLYTA, VRAYLAR, REXULTI, SPRAVATO, INVEGA SUSTENNA, Auvelity, UZEDY, ABILIFY MAINTENA.
Industry payments across MA — which companies pay providers there.
